Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib and Pomalidomide with Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01464034Phase 2Terminated
- Sponsor
- Criterium
- Start
- Nov 2011
- Primary completion
- Jul 2020
- Modality
- Reversible Covalent Inhibitors, Irreversible Covalent Inhibitors, Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib, pomalidomide in multiple myeloma (MM), sponsored by Criterium. Started Nov 2011; status: terminated.
02
Drugs
carfilzomibpomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01464034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464034.